Health-related quality of life in children with osteogenesis imperfecta: a large-sample study

[21] Zhao D(2011)Functional outcome in osteogenesis imperfecta: disability profiles using the PEDI J Pediatr Rehabil Med 4 1877-902

[22] Xu X(2014)Osteogenesis imperfecta in childhood: impairment and disability J Pediatr Orthop 34 11-129

[23] Lv F(2016)Activities and participation in young adults with osteogenesis imperfecta [comparative study] Qual Life Res 25 2507-143

[24] Li L(2016)Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy Bone 87 891-undefined

[25] Jiang Y(2017)The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review Drug Des Devel Ther 11 123-undefined

[26] Wang O(2018)Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate Eur J Pediatr 177 137-undefined

[27] Xia W(2017)Therapy with pamidronate in children with osteogenesis imperfecta Pediatr Endocrinol Rev 15 152-undefined

[28] Xing X(2018)Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle Bone 113 undefined-undefined

[29] Li M(2015)Correlation of bone mineral density on quality of life in patients with osteogenesis imperfecta during treatment with denosumab Orphanet J Rare Dis 10 undefined-undefined

[30] Xu XJ(undefined)A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood undefined undefined undefined-undefined

[21] Zhao D(2011)Functional outcome in osteogenesis imperfecta: disability profiles using the PEDI J Pediatr Rehabil Med 4 1877-902

[22] Xu X(2014)Osteogenesis imperfecta in childhood: impairment and disability J Pediatr Orthop 34 11-129

[23] Lv F(2016)Activities and participation in young adults with osteogenesis imperfecta [comparative study] Qual Life Res 25 2507-143

[24] Li L(2016)Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy Bone 87 891-undefined

[25] Jiang Y(2017)The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review Drug Des Devel Ther 11 123-undefined

[26] Wang O(2018)Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate Eur J Pediatr 177 137-undefined

[27] Xia W(2017)Therapy with pamidronate in children with osteogenesis imperfecta Pediatr Endocrinol Rev 15 152-undefined

[28] Xing X(2018)Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle Bone 113 undefined-undefined

[29] Li M(2015)Correlation of bone mineral density on quality of life in patients with osteogenesis imperfecta during treatment with denosumab Orphanet J Rare Dis 10 undefined-undefined

[30] Xu XJ(undefined)A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood undefined undefined undefined-undefined